Menu
Recruiting NCT05267041

Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)

No phase Interventional Lung Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Blood sample, Questionnaire.
Who it may be relevant to
Registry conditions: Lung Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Prospective Longitudinal Cohort Associated to Blood Collection, Pathological Samples Collection, and Radiological and Pathological Imaging Collection

Overview

Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.

Interventions

  • Biological Blood sample
    One optional veinous blood sampling (24 ML) between the first diagnostic annoucement and before the first treatment for lung cancer
  • Other Questionnaire
    to collect data not reported in the patient's medical file, such as passive smoking, family history of cancer, and attempts to quit smoking.

Primary outcome measures

  • Number of participants registered in the lung cancer database [Time frame: 20 years]

Eligibility criteria

Inclusion criteria

  • Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma…
  • Diagnosis can be done:
  • By cytology or pathologic assessment
  • Or by multidisciplinary team meeting decision:
  • Irradiation without morpho-metabolic sampling
  • Treatment without sampling based on non-invasive molecular data

Exclusion criteria

\- Refusal to participate

For optional blood sampling :

  • < 30 kg for blood collection
  • No blood sampling schedule for care

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • Centre Hospitalier Lyon Sud — Pierre-Bénite

Identifiers

NCT: NCT05267041 · 69HCL21_1175

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗